BAM
CERE
Blueshift Asset Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,791
| Closed | -$441K | – | 496 |
|
|
2024
Q2 | $441K | Buy |
10,791
+4,054
| +60% | +$166K | 0.15% | 190 |
|
|
2024
Q1 | $285K | Buy |
+6,737
| New | +$285K | 0.15% | 207 |
|
|
2022
Q2 | – | Sell |
-10,268
| Closed | -$359K | – | 1060 |
|
|
2022
Q1 | $359K | Buy |
+10,268
| New | +$359K | 0.03% | 558 |
|